The Board resolution No.39 dated August 11, 2020, the BOD of Imexpharm Corporation (IMP) approved the following issues:

1)      Approving the stock issuance under ESOP:

-          Stock type: common share

-          Number of outstanding shares at 12/31/2019: 49,387,359 shares

-          Number of shares expected to be issued: 2,469,300 shares, equivalent to 5% number of outstanding shares

-          Par value: VND 10,000/share

-          Issue price: VND 12,000/share

-          Time of implementation: Quarter 3.2020 and Quarter 4.2020

-          Transfer restriction time: according to the regulation of stock issuance under ESOP.

2)      Approving the dossier of stock issuance under ESOP:

-          Report on stock issuance under ESOP (PL18);

-          Minutes & Resolution of 2020 General Meeting of Shareholders; Proposal No.24/TTr-HĐQT-IMP dated May 14, 2020 regarding the additional issuance to raise charter capital.

-          Minutes & Board resolution dated August 11, 2020;

-          Decision on enforcing the Regulation of stock issuance under ESOP by the Board of Directors.

-          Explanation of voting rate at the 2020 General Meeting of Shareholders of the related persons related in the ESOP list.

-          Audited financial statements in 2019; Reviewed financial statements in six months of 2020.